RPG Life Sciences Ltd. Financials: Quarterly Results
Revenue
183.44
Cr.
PAT
22.13
Cr.
EBITDA
37.79
Cr.
RPG Life Sciences Ltd. Q3FY26 Financial Metrics
| Indicator | Dec-25 | Sep-25 | Dec-24 |
|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 180.03 | 181.68 | 172.71 |
| Total Income From Operations (Cr.) | 180.03 | 181.68 | 172.71 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | 37.79 | 38.35 | 47.01 |
| P/L Before Exceptional Items & Tax (Cr.) | 37.54 | 38.23 | 46.89 |
| P/L After Tax from Ordinary Activities (Cr.) | 22.13 | 36.85 | 34.93 |
| Net Profit/Loss For the Period (Cr.) | 22.13 | 36.85 | 34.93 |
| Basic EPS | 13.38 | 22.28 | 21.12 |
FAQs
RPG Life Sciences Ltd. announced its quarterly results for Q3 FY2026 on January 28, 2026.
In Q3 FY2026, RPG Life Sciences Ltd. are as follows:
Revenue: ₹183.44 crore
Net Profit: ₹22.13 crore.
For Q3 FY2026, RPG Life Sciences Ltd. posted ₹183.44 crore in revenue and ₹22.13 crore in net profit.
Past quarterly results for RPG Life Sciences Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.